Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Noura A. Matar"'
Autor:
Lamia M. Hafez, Hebatallah Mohammed Aboudeya, Noura A. Matar, Ashraf S. El-Sebeay, Azhar Mohamed Nomair, Shaymaa Ali El-hamshary, Hanan Mohamed Nomeir, Fawziya A. R. Ibrahim
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract Obesity has been associated with cognitive impairments, increasing the probability of developing dementia. Recently, zinc (Zn) supplementation has attracted an increasing attention as a therapeutic agent for cognitive disorders. Here, we inv
Externí odkaz:
https://doaj.org/article/cb4e8d9f769b43d4a197bedebe778741
Autor:
Passant M. Elhalmoushy, Manal A Elsheikh, Noura A. Matar, Wessam F. El-Hadidy, Maher A Kamel, Gamal A. Omran, Yosra S.R. Elnaggar
Publikováno v:
Journal of Drug Delivery Science and Technology. 80:104119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::703b48eaff825fdc5d3779a932d8570f
https://doi.org/10.1016/j.jddst.2022.104119
https://doi.org/10.1016/j.jddst.2022.104119
Autor:
Passant M. Elhalmoushy, Manal A Elsheikh, Noura A. Matar, Wessam F. El-Hadidy, Maher A Kamel, Gamal A. Omran, Yosra S.R. Elnaggar
Publikováno v:
International journal of pharmaceutics. 615
Vitiligo is a depigmentation disorder that affects 0.5-2% of the world population. It has a severe impact on a patient's quality of life and even causes suicidal attempts. Up to date, no curative therapy is available which have created a substantial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea94753d78694ae2284a19d9fb66f061
https://pubmed.ncbi.nlm.nih.gov/35104596
https://pubmed.ncbi.nlm.nih.gov/35104596
Publikováno v:
Life Sciences. 306:120812
The chronic administration of vitamin C and E can differentially disrupt hepatic insulin molecular pathway in rats. Hence, this study evaluated their effects on lipogenesis in the liver and adipose tissue and investigated the possible involvement of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b891214f3d0f63bd618f5f4e0ff09d9
https://doi.org/10.1016/j.lfs.2022.120812
https://doi.org/10.1016/j.lfs.2022.120812
Autor:
Mennatallah A. Gowayed, Norhan S. El-Sayed, Noura A. Matar, Elham A. Afify, Samar O. El-Ganainy
Publikováno v:
Biomedicine & Pharmacotherapy. 148:112776
Parkinson's disease (PD) is the second most common neurodegenerative disorder and a leading cause of disability. The current gold standard for PD treatment, L-Dopa, has limited clinical efficacy and multiple side effects. Evidence suggests that activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652dcdd17309be7e4a99798334ffdc16
https://doi.org/10.1016/j.biopha.2022.112776
https://doi.org/10.1016/j.biopha.2022.112776